GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain



Status:Completed
Conditions:Chronic Pain, Chronic Pain, Migraine Headaches, Neurology
Therapuetic Areas:Musculoskeletal, Neurology
Healthy:No
Age Range:8 - 18
Updated:4/17/2018
Start Date:October 2013
End Date:January 2018

Use our guide to learn which trials are right for you!

The broad aim of the study is to implement and evaluate the efficacy of Graded Exposure
Treatment (GET Living) to target elevated pain-related fears in children with chronic pain.
Pain-related fear is an important psychological factor associated with poor outcomes in
children suffering with chronic pain. To examine the efficacy of GET Living in addressing
pain-related fears the investigators propose to use a sequential replicated randomized
single-case experimental phase design with multiple measures. The specific aims are to 1)
evaluate the effectiveness and acceptability of individually tailored GET Living for children
with high pain-related fear and functional disability and 2) define anatomical and resting
state connectivity patterns in the brains of children and adolescents with complex chronic
pain prior to and after participation in GET Living.


Inclusion Criteria:

- Pain-related fear (score >40 on the Fear of Pain Questionnaire (FOPQ (Simons et al.,
2011a))

- Musculoskeletal, neuropathic limb or back pain, or headache

- Functional limitations (score > 12 on the Functional Disability Inventory (FDI
(Kashikar-Zuck et al., 2001; Walker and Greene, 1991)).

Exclusion Criteria:

- Significant cognitive impairment (e.g., intellectual disability)

- Serious psychopathology (e.g., active suicidality).

- Acute trauma (e.g., spondylolithesis, disk herniation, fracture, acute tendonitis)

- Systemic disease in active inflammatory state

- Biomechanical deficit that would limit ability to engage in exposure activities (e.g.
severe muscle atrophy)

- Making gains in current physical therapy or have not had physical therapy, but it is
clearly indicated
We found this trial at
1
site
Waltham, Massachusetts 02453
Principal Investigator: Laura Simons, PhD
?
mi
from
Waltham, MA
Click here to add this to my saved trials